Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 460 of 6351
-
New hope for tough lung cancer: tarlatamab trial opens
Disease control Recruiting nowSTART-lung is an international, multicentre, single-arm phase II trial. Protocol treatment consists of tarlatamab administered as an intravenous infusion until disease progression according to RECIST v1.1 criteria, unacceptable toxicity, or patient decision, whichever comes first…
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Hope for mitochondrial disease: new drug targets debilitating fatigue
Symptom relief Recruiting nowThe KHENERFIN study aims to determine whether the study medicine, sonlicromanol, is able to reduce symptoms of fatigue and the impact of fatigue on daily life, and whether sonlicromanol is able to improve physical abilities of people like balance control and lower limb skeletal m…
Phase 3 • Sponsor: Khondrion BV • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a bone drug ease CRPS pain? large trial underway
Symptom relief Recruiting nowPhase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
Phase 3 • Sponsor: Ambros Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New drug duo aims to fight recurrent head and neck cancer
Disease control Recruiting nowThis study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab compared against cemiplimab combined with placebo (a placebo looks like a treatment but does not contain any real medicine), collectively called "s…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New dual-target CAR-T therapy takes on hard-to-treat plasma cell cancers
Disease control Recruiting nowThis is a single arm study to evaluate the safety and efficacy of CAR BCMA-CD70 CAR-T cell therapy for high-risk plasma cell neoplasms.
Early phase 1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Which scope technique wins for tiny rectal tumors?
Disease control Recruiting nowUnderwater endoscopic mucosal resection (UEMR) and endoscopic submucosal dissection (ESD) have both been reported to be two effective treatment methods for small rectal neuroendocrine tumor (NET). However, there is no consensus on the best method for the endoscopic resection of r…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Balloon in the aorta could boost CPR success
Disease control Recruiting nowThis study will test if a sustained Return of Spontaneous Circulation (ROSC) in patients with cardiac arrest is more frequent when patients receive advanced cardiac life support (ACLS) alone or when they receive ACLS plus a balloon occlusion of the thoracic aorta.
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Radiation boost before transplant may tackle stubborn blood cancers
Disease control Not yet recruitingApplication of Stereotactic Body Radiotherapy (SBRT) Bridging to Allogeneic Hematopoietic Stem Cell Transplantation in Adult Hematological Malignance Patients with Extramedullary Lesions. This study aims to improve transplantation outcomes with extramedullary lesions. The investi…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could tailored tamoxifen doses keep more breast cancer patients on treatment?
Disease control Recruiting nowIn Sweden, approximately 7000 women are diagnosed with hormone-sensitive breast cancer annually. According to international and national guidelines, most of these women are recommended anti-hormonal therapy for five to ten years to improve prognosis. Tamoxifen, one of the most wi…
Phase 3 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New TB combo drug trial aims to shorten treatment
Disease control Recruiting nowThe purpose of this study is to evaluate if TBD09 in combination with other active agents in adults with drug sensitive pulmonary tuberculosis has potential to be safe and effective.
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New shot could tame stubborn hives for good
Symptom relief Not yet recruitingThis study is a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial aimed at evaluating the efficacy and safety of MG-K10 humanized monoclonal antibody injection in CSU trial participants with poor control of second-generation H1 antihistamines.
Phase 3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Scientists probe hidden clues to immunotherapy success in endometrial cancer
Knowledge-focused Recruiting nowIn recent years, the introduction of immune checkpoint inhibitors (ICI) in combination with chemotherapy has significantly changed the management of advanced and recurrent Endometrial Cancer (EC). Despite these advances, responses to immunotherapy remain heterogeneous. Not all p…
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
A gentle jog might be the key to better sleep for breast cancer survivors
Symptom relief Recruiting nowBreast cancer survivors frequently experience persistent sleep disturbance, cancer-related fatigue, and reduced health-related quality of life after completion of primary treatment. Although exercise is recommended as an important component of survivorship care, evidence regardin…
Sponsor: Mackay Memorial Hospital • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New study tests High-Tech glucose tracking to stop diabetes before it starts
Prevention Recruiting nowPrediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program…
Sponsor: State University of New York at Buffalo • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New lupus drug aims to help patients stop steroids
Disease control Recruiting nowThe purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in LLDAS at enrolment. Patients …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
New drug combo offers hope for tough head and neck cancers
Disease control Recruiting nowThis is a single-arm, open-label, phase II study to evaluate the efficacy and safety of the combination of the antibodies iparomlimab and tuvonralimab, administered with or without chemotherapy, in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M H…
Sponsor: The Second Affiliated Hospital of Hainan Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for tough lymphomas: experimental drug MDX2003 enters human testing
Disease control Recruiting nowThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2003 in patients with different types of lymphoma
Phase 1/2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Cancer drug venetoclax takes aim at HIV's secret hiding spots
Disease control Recruiting nowCombination therapy with antiretroviral medication (ART) has proven effective in keeping HIV suppressed and restoring the immune system, but it cannot cure the infection. Therefore, lifelong treatment is necessary. The reason for this is a reservoir of inactive virus that remains…
Phase 1 • Sponsor: Thomas Aagaard Rasmussen • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New weekly shot aims to melt weight and soothe aching knees
Symptom relief Recruiting nowThe purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and knee osteoarthritis. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Blood test could personalize melanoma treatment, study hopes
Disease control Recruiting nowThe purpose of this study is to investigate the use of ctDNA measurements to guide first-lien therapy choice for patients with advanced or metastatic melanoma. Primary endpoints include progression-free survival. Secondary study endpoints include objective response rate and incid…
Phase 2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC